IDSA 2026 Guidelines: No Such Publication Exists
There are no IDSA guidelines published in 2026, as this year has not yet occurred. The most recent IDSA guidelines available are from 2025 and earlier.
Available Recent IDSA Guidelines (2025)
Based on the evidence provided, the most current IDSA guidelines include:
2025 Guidelines Published:
Complicated Urinary Tract Infections (cUTI) 1, 2
- Antibiotic selection for cUTI
- Duration of therapy (5-7 days for most patients improving on effective therapy, regardless of bacteremia)
- 10-14 days only for men with suspected acute bacterial prostatitis
Histoplasmosis Management 3, 4
- Treatment of asymptomatic pulmonary nodules (histoplasmomas)
- Management of mild to moderate acute pulmonary histoplasmosis
COVID-19 Treatment 5
- Antiviral treatment for mild to moderate COVID-19 in adults
- Use of nirmatrelvir/ritonavir, remdesivir, and molnupiravir
Respiratory Virus Vaccination in Immunocompromised Patients 6, 7
- RSV, COVID-19, and Influenza vaccination recommendations
- Strong recommendation for age-appropriate vaccination in immunocompromised adults and adolescents
Most Recent Guidelines by Topic (Pre-2025):
- Complicated Intra-abdominal Infections: 2024 update 8 with 2010 treatment recommendations 9
- Skin and Soft Tissue Infections: 2014 10
- Diabetic Foot Infections: 2012 11
- Neutropenic Fever: 2011 12
How to Find Current Guidelines
To access the most up-to-date IDSA guidelines, visit the official IDSA website at www.idsociety.org/practice-guideline or search PubMed for recent publications in Clinical Infectious Diseases.
If you're seeking guidance on a specific infection or clinical scenario, please clarify which condition you need recommendations for, and I can provide the most recent evidence-based guidance available.